knowledge -WSS

knowledge

author：explore 2025-10-02 01:09:03 - browse：47985

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： The explosion of genetic testing requires a new approach

WSS

Pharmacists can make shortage drugs, but at what cost?

Hospital price transparency does save money, advocate argues

World's first CRISPR

U.K. considers world's first use of meningitis vaccine to address gonorrhea

STAT Summit: Michael J. Fox on progress in Parkinson's research

Beam Therapeutics to lay off 20% of its staff, re

Wikipedia

knowledge

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

STAT Readout Newsletter: Today's biggest biotech updates

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Anthos stroke drug appears safer than common blood thinner

Anesthesiologist group: stop taking Ozempic before surgery

The EU Joint Clinical Assessment needs to live up to its promise

As demand for Covid shots wanes, Moderna seeks its next success

Why medical students are struggling with mental health

Trump demands the U.S. pay no more for drugs than other countries … again

Poor hospice wound care hurts patients and families

explore

STAT Summit: Michael J. Fox on progress in Parkinson's research

Gain of function research would be limited under House proposal

STAT Readout Newsletter: Today's biggest biotech updates

FDA struggles to regulate food additives, sometimes for decades

FDA struggles to regulate food additives, sometimes for decades

Hospital price transparency does save money, advocate argues

hotspot

hotspot

Wikipedia

explore